213 related articles for article (PubMed ID: 15181415)
1. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
Baratto F; Michielan F; Gagliardi G; Di Gregorio G; Pasqualetto A; Meroni M; Giron GP
Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
[TBL] [Abstract][Full Text] [Related]
2. Use of protein C concentrate in pediatric patients with sepsis.
Silvani P; Camporesi A; Licari E; Wolfler A
Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
[TBL] [Abstract][Full Text] [Related]
3. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
[TBL] [Abstract][Full Text] [Related]
4. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
[TBL] [Abstract][Full Text] [Related]
5. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
[TBL] [Abstract][Full Text] [Related]
6. Protein C concentrate as adjuvant treatment in neonates with sepsis-induced coagulopathy: a pilot study.
Decembrino L; D'Angelo A; Manzato F; Solinas A; Tumminelli F; De Silvestri A; De Lazzari S; Padovani E; Magarotto M; Chiandetti L; Saia SO; Stronati M
Shock; 2010 Oct; 34(4):341-5. PubMed ID: 20823695
[TBL] [Abstract][Full Text] [Related]
7. [Use of protein C concentrate in critical conditions: clinical experience in pediatric patients with sepsis].
Pettenazzo A; Malusa T
Minerva Anestesiol; 2004 May; 70(5):357-63. PubMed ID: 15181416
[TBL] [Abstract][Full Text] [Related]
8. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
9. Protein C concentrate to restore physiological values in adult septic patients.
Baratto F; Michielan F; Meroni M; Dal Palù A; Boscolo A; Ori C
Intensive Care Med; 2008 Sep; 34(9):1707-12. PubMed ID: 18458873
[TBL] [Abstract][Full Text] [Related]
10. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
Schellongowski P; Bauer E; Holzinger U; Staudinger T; Frass M; Laczika K; Locker GJ; Quehenberger P; Rabitsch W; Schenk P; Knöbl P
Vox Sang; 2006 May; 90(4):294-301. PubMed ID: 16635072
[TBL] [Abstract][Full Text] [Related]
11. [Protein C concentrate in the treatment of severe sepsis in the pediatric setting].
Ramos Guerrero R; López Castilla JD; Atienza Fernández M; Bautista Paloma J; Ramos Guerrero AJ; Muñoz Sáez M; Carranza Conde M; Soult Rubio JA
Farm Hosp; 2003; 27(6):391-5. PubMed ID: 14974885
[TBL] [Abstract][Full Text] [Related]
12. Use of activated protein C in liver transplantation patients with septic shock.
Rinaldi L; Marietta M; Mignini MA; Donno L; Busani S; Codeluppi M; Masetti M; Girardis M
Liver Transpl; 2008 Nov; 14(11):1598-602. PubMed ID: 18972572
[TBL] [Abstract][Full Text] [Related]
13. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
14. Acute renal failure in patients with severe sepsis and septic shock--a significant independent risk factor for mortality: results from the German Prevalence Study.
Oppert M; Engel C; Brunkhorst FM; Bogatsch H; Reinhart K; Frei U; Eckardt KU; Loeffler M; John S;
Nephrol Dial Transplant; 2008 Mar; 23(3):904-9. PubMed ID: 18065435
[TBL] [Abstract][Full Text] [Related]
15. Levels of protein C activity and clinical factors in early phase of pediatric septic shock may be associated with the risk of death.
Samransamruajkit R; Hiranrat T; Prapphal N; Sritippayawan S; Deerojanawong J; Poovorawan Y
Shock; 2007 Nov; 28(5):518-23. PubMed ID: 17589380
[TBL] [Abstract][Full Text] [Related]
16. The current management of septic shock.
Russel JA
Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
[TBL] [Abstract][Full Text] [Related]
17. [Early changes in function of hypothalamic-pituitary-target gland axis in patients with severe sepsis and septic shock].
Cui N; Liu DW; Wang H; Zeng ZP; Long Y; Chai WZ; Liu HZ; Wang XT
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun; 19(6):332-5. PubMed ID: 17577436
[TBL] [Abstract][Full Text] [Related]
18. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA
Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
[TBL] [Abstract][Full Text] [Related]
19. Use of IgM and IgA-enriched immunoglobulins in the treatment of severe sepsis and septic shock. Clinical experience.
Berlot G; Dimastromatteo G
Minerva Anestesiol; 2004 Oct; 70(10):739-43; 743-5. PubMed ID: 15516885
[TBL] [Abstract][Full Text] [Related]
20. Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis.
Lindstrom O; Kylanpaa L; Mentula P; Puolakkainen P; Kemppainen E; Haapiainen R; Fernandez JA; Griffin JH; Repo H; Petaja J
Crit Care; 2006 Feb; 10(1):R16. PubMed ID: 16420659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
